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The MYH (MutY glycosylase homologue) increases replic-
ation ﬁdelity by removing adenines or 2-hydroxyadenine mis-
incorporated opposite GO (7,8-dihydro-8-oxo-guanine). The 9-
1-1 complex (Rad9, Rad1 and Hus1 heterotrimer complex) has
been suggested as a DNA damage sensor. Here, we report that
hMYH (human MYH) interacts with hHus1 (human Hus1) and
hRad1 (human Rad1), but not with hRad9. In addition, inter-
actions between MYH and the 9-1-1 complex, from both the ﬁs-
sion yeast Schizosaccharomyces pombe and human cells, are par-
tiallyinterchangeable.ThemajorHus1-bindingsiteislocalizedto
residues 295–350 of hMYH and to residues 245–293 of SpMYH
(S. pombe MYH). Val
315 of hMYH and Ile
261 of SpMYH play
important roles for their interactions with Hus1. hHus1 protein
and the 9-1-1 complex of S. pombe can enhance the glycosylase
activity of SpMYH. Moreover, the interaction of hMYH–hHus1
is enhanced following ionizing radiation. A signiﬁcant fraction
of the hMYH nuclear foci co-localizes with hRad9 foci in H2O2-
treated cells. These results reveal that the 9-1-1 complex plays a
direct role in base excision repair.
Key words: base excision repair, DNA damage checkpoint, DNA
glycosylase, ﬁssion yeast, Hus1, MutY glycosylase homologue
(MYH).
INTRODUCTION
Oxidative damage to DNA can induce mutagenesis and lead to
degenerativediseases.Oneofthemostabundantandhighlymuta-
genic type of oxidative damage to DNA is GO (7,8-dihydro-8-
oxo-guanine). If not repaired, GO lesions in DNA can produce
A/GO (adenine/GO) mismatches during DNA replication [1] and
result in G:C to T:A transversions [2,3]. hMYH [human MYH
(MutY glycosylase homologue)] reduces G:C to T:A mutations
by removing adenines or 2-hydroxyadenines mispaired with gua-
nines or GO that arise through DNA replication errors [4–6].
Germline mutations in the hMYH gene cause autosomal recessive
colorectal adenomatous polyposis, which is characterized by
multiple adenomas, some of which progress to cancer [7,8].
Cell-cycle checkpoints are surveillance mechanisms that moni-
tor the cell’s state, maintain telomere stability and preserve gen-
omicintegrity(reviewedin[9]).Thesignaltransductionpathways
triggered by DNA damage involve many components including
sensors, transducers and effectors. Human ATM (ataxia telangi-
ectasia mutated) and ATR (ATM- and Rad3-related protein) are
phosphoinositol phosphate 3-kinase-related kinases. After stress,
ATM or ATR is activated and can transduce the DNA damage
signalbyphosphorylatingmanyproteinsinaRad9-,Rad1-,Hus1-
and Rad17-dependent manner. Rad9, Rad1 and Hus1 form a
heterotrimercomplex[referredasthe9-1-1complex(Rad9,Rad1
and Hus1 heterotrimer complex)] that has predicted structural
homology to PCNA (proliferating-cell nuclear antigen) sliding
clamp [10,11]. Rad17 protein is a paralogue of the largest subunit
of RFC (replication factor C), and it forms the alterative clamp
loader with RFC2-5. The 9-1-1 complex is loaded on to DNA by
Rad17–RFC[12,13].hATM/hATR,the9-1-1complexandRad17
are proposed to act at an early step of DNA damage response to
sensetheDNAdamageandtoleadtocell-cyclearrestorapoptosis
(reviewed in [9]). It has been suggested that these checkpoint
proteins may detect a common intermediate, such as single-
stranded DNA coated by RPA (replication protein A), which is
processed by various DNA repair pathways [14]. RPA has been
shown to directly interact with the 9-1-1 complex [15]. Recently,
several reports support a hypothesis that checkpoint proteins may
require a series of ‘adaptors’ to recognize DNA damage [16–18].
Such adaptor proteins may be DNA damage recognition proteins
involved in mismatch repair, nucleotide excision repair and
double-strand break repair.
We have shown that MYH is directly associated with PCNA
in both the ﬁssion yeast Schizosaccharomyces pombe and human
cells [19,20]. It has been suggested that the coupling between the
hMYH base excision repair pathway and DNA replication may
provide a signal to target the MYH repair to the daughter DNA
strands [20–22]. In addition, we have shown that the S. pombe
9-1-1 complex is associated with SpMYH (S. pombe MYH) and
that the DNA-damage-induced SpHus1 (S. pombe Hus1) phos-
phorylation is dependent on SpMYH expression [23]. In the pre-
sent study, we show that hMYH physically interacts with hHus1
(human Hus1) and hRad1 (human Rad1), but not with hRad9.
Interactions between MYH and the 9-1-1 complex, from both
S. pombe and human cells, are partially interchangeable. hHus1
interacts with hMYH at a region that is different from the PCNA-
interacting motif. We demonstrate, for the ﬁrst time, that Val
315 of
hMYH and Ile
261 of SpMYH are important for Hus1 interaction.
The DNA glycosylase activity of SpMYH is stimulated by hHus1
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and the S. pombe 9-1-1 complex. Moreover, the interaction of
hMYH–hHus1 is enhanced by ionizing radiation. A signiﬁcant
fraction of the hMYH nuclear foci co-localizes with hRad9 foci
inH2O2-treatedcells.Recently,the9-1-1complexhasbeenshown
to interact with and stimulate the enzymes involved in base
excision repair, which include polymerase β [24], FEN1 (ﬂap
endonuclease1)[25,26]and DNA ligase 1[27,28].Thusthe 9-1-1
complex serves both as a damage sensor and as a component of
base excision repair.
MATERIALS AND METHODS
Human cell lines and extracts
Human HeLa cell line was purchased from American Type Cell
Culture (Manassas, VA, U.S.A.). The HeLa cells were grown in
Joklik’s minimum Eagle’s medium with 5% (v/v) fetal bovine
serum, 2 g/l NaHCO3,1 % non-essential amino acids, 4 mM L-
glutamine and 1% penicillin/ streptomycin at 37◦Ci n5% CO2.
Cells in T25 ﬂasks were grown to approx. 80% conﬂuence,
treatedby10GyirradiationonaPantakHF320X-raymachineand
then recovered at different times in serum-free media. HeLa cells
were treated with 5 mM H2O2 for 40 min and then recovered in
serum-free media for 6 h. Nuclear and cell extracts were prepared
asdescribedin[20,29].Theproteinconcentrationwasdetermined
by the Bio-Rad protein assay (Bio-Rad).
GST (glutathione S-transferase) fusion protein constructs
The constructs of GST fusions of intact,  C1,  C2 and  N2
hMYH,aswellasGST–SpMYH-(245–461),havebeendescribed
[20,23]. The cDNA fragments containing residues 1–350 of
hMYH ( C3), residues 351–535 of hMYH ( N5) and residues
294–461 of SpMYH fused to the GST gene were made by PCR
method (see Supplementary material at http://www.BiochemJ.
org/bj/400/bj4000053add.htm). The PCR products were digested
withBamHIandXhoIandligatedintotheBamHI–XhoI-digested
pGEX-4T-2vector(GEHealth).TheV315AmutantofthehMYH
gene and the I261A mutant of the SpMYH gene were constructed
by the PCR splicing overlap extension method [30] (see Supple-
mentarymaterial).TheplasmidspGEX-3X-hHus1(hHus1coding
region inserted at BamHI and XhoI sites) and pGEX-4T3-hRad9
(hRad9 coding region inserted at BamHI and EcoRI sites),
whichcontainedGST-taggedhHus1andhRad9respectively,were
obtained from Dr A. E. Tomkinson (University of Maryland,
Baltimore, MD, U.S.A.). The pGEX-3X-hRad1 plasmid (Rad1
coding region inserted at BamHI and EcoRI sites) was obtained
from Dr E. Y. Lee (University of California, Irvine, CA, U.S.A.)
through Dr A. E. Tomkinson.
GST pull-down assay
TheGSTpull-downassaywassimilartothedescribedprocedures
[20].TheGST-taggedproteinswereexpressedinEscherichiacoli
(BL21-Star/DE3) cells (Stratagene), which harbour the express-
ion plasmids, and immobilized on glutathione–Sepharose 4B.
The beads, containing approx. 300 ng of proteins, were incubated
with0.1 µgoftargetproteins,0.4 mgofnuclearextractsor0.3 µg
of partially puriﬁed S. pombe 9-1-1 complex overnight at 4◦C. A
control was run concurrently with immobilized GST alone. After
centrifugation at 1000 g for 2 min, the pellets were washed four
times. The pellets were analysed on a 10% polyacrylamide gel
containing SDS and transferred to a nitrocellulose membrane.
Western-blot analyses were performed (see below).
Co-immunoprecipitation
HeLa whole cell extracts (0.8 mg) were precleared by adding
30 µl of Protein G–agarose (Invitrogen) for 1–4 h at 4◦C. After
centrifugation at 1000 g for 2 min, the supernatant was incubated
with1 µgofanti-hMYHpeptide516(α516againstresidues516–
534) antibodies [31] overnight at 4◦C. Protein G–agarose (30 µl)
was added and incubated for 4–12 h at 4◦C. After centrifugation
at 1000 g for 2 min, the supernatant was saved and the pellet was
washed. Both the supernatant (∼10% of total volume) and pellet
fractions were resolved by SDS/10% PAGE and Western-blot
analyses for PCNA and hHus1 were performed (see below).
Western blotting
Proteins were fractionated by SDS/PAGE and transferred to a
nitrocellulose membrane. The membranes were allowed to react
with antibodies against an hMYH peptide (α516) [31], SpMYH
[32], hPCNA (human PCNA) (Calbiochem–Novabiochem),
hHus1 (sc-8323; Santa Cruz Biotechnology), HA (haemaggluti-
nin) probe (sc-7392; Santa Cruz Biotechnology), N-terminal
histidine-probe (sc-8036; Santa Cruz Biotechnology), C-ter-
minalhistidine-probe(Invitrogen),S-tag(sc-802;SantaCruzBio-
technology) and actin (sc-1616; Santa Cruz Biotechnology).
Western blotting was detected by the ECL® (enhanced chemi-
luminescence) analysis system (GE Health) according to the
manufacturer’s protocol.
Expression and puriﬁcation of the hHus1 protein
The E. coli BL21-Star cells (Stratagene) that harbour the express-
ion plasmid of hHus1–His protein (see Supplementary material)
were grown and induced such as for GST–hMYH. The hHus1–
His protein was puriﬁed by Ni-NTA (Ni
2+-nitrilotriacetate) resin
(Qiagen) under native conditions according to the manufacturer’s
protocol. The hHus1–His protein was dialysed twice with TEG
buffer (50 mM Tris/HCl, pH 7.4, 0.1 mM EDTA, 50 mM KCl,
10% glycerol, 0.5 mM dithiothreitol and 0.1 mM PMSF) and
furtherpuriﬁedbya1 mlheparincolumn(GEHealth)equilibrated
with TEG buffer. Upon washing with 5 ml of equilibration buffer,
the column was eluted with a 30 ml linear gradient of KCl (0.05–
0.8 M) in TEG buffer. The fractions that contain most of the
hHus1–His protein eluted at 0.5 M KCl. This was conﬁrmed by
SDS/PAGE and Western blotting with histidine antibody (Santa
Cruz Biotechnology). The fractions were then divided into small
aliquots and stored at −80◦C. The protein concentration was
determined by the Bradford method [33].
Expression and puriﬁcation of the recombinant
SpRad9–Rad1–Hus1 complex
E. coli BL21-Star cells (Stratagene), harbouring both pET21a-
SpHus1 and pACYCD-SpRad1-SpRad9 (see Supplementary
material), were grown and induced such as for GST–hMYH.
The 9-1-1 complex was puriﬁed from 14 g of cell paste by 45%
ammonium sulfate precipitation, heparin and phosphocellulose
chromatographies similar to the described procedures [34]. Frac-
tion V (the pool from phosphocellulose column) was precipitated
by 45% ammonium sulfate and dialysed against buffer A con-
taining200 mMKCltoobtainFVAd.Thesamplewasthendivided
intosmallaliquotsandstoredat−80◦C.TheFVAd(0.2 ml,31 µg
of protein) was layered on top of 5.0 ml 15–35% (v/v) glycerol
gradient. The gradients were spun for 22 h at 45000 rev./min in
an AH650 rotor (Sovall) at 4◦C. The fractions of two drops were
collected from the bottom of the tube and aliquots were analysed
by SDS/PAGE and Western blotting. The elution positions of the
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marker proteins (bovine thyroglobin, apoferritin, β-amylase and
BSA) were determined by Coomassie Blue staining.
Other proteins used
The recombinant SpMYH expressed in E. coli was puriﬁed as de-
scribed in [35]. HA-tagged SpHus1 in S. pombe extracts has been
described [23]. Histidine-tagged SpHus1 in E. coli extracts was
prepared from Rosetta cells (EMD Biosciences) that expressed
pET21a-SpHus1 (see Supplementary material). hMYH, with
streptococcal Protein G (GB1 domain) at its N-terminus and a 6-
Histidine tag at its C-terminus, was partially puriﬁed as described
in [36].
Assays of SpMYH binding and glycosylase activities
The binding and glycosylase assays for puriﬁed recombinant
SpMYH with an A/GO-containing DNA were described pre-
viously [35]. The DNA substrate was a 20-mer duplex DNA
containing an A/GO mismatch (see Supplementary Table S1
in Supplementary material at http://www.BiochemJ.org/bj/400/
bj4000053add.htm) that was labelled at the 5
 -end of the mis-
matched A-containing strand as described in [34].
Immunoﬂuorescent staining
HumanHeLacellsweregrowninLab-Tekchamberslides(Nunc)
overnight, treated with 5 mMH2O2 f or40m i na ndt he nr e c o v e r e d
in serum-free media for 6 h. The cells were ﬁxed with 4% for-
maldehyde for 15 min and permeabilized at room temperature
(23◦C) in PBS+0.1% Triton for 10 min. After being blocked in
PBS containing 15% fetal bovine serum for 15 min at 37◦C, the
cells were reacted with hMYH polyclonal antibody and hRad9
monoclonal antibody (Imgenex) at 37◦C for 30 min. Next, the
cells were washed three times for 15 min each in PBS and
incubated with Alexa Fluor® 594 goat anti-rabbit and Alexa
Fluor® 488goatanti-mouseIgGantibodies(Invitrogen)ata1:250
dilution in PBS for 30 min at 37◦C. The cells were then washed
three times in PBS. Nuclear DNA was counterstained with DAPI
(4
 ,6
 -diamidino-2-phenylindole; Vector Laboratories). Images
were captured with a Nikon E400 ﬂuorescent microscope with an
attached CCD (charge-coupled-device) camera.
RESULTS
Human MYH physically interacts with hHus1 and hRad1, but not
with hRad9
Because we have shown that the S. pombe PCNA-like 9-1-1 com-
plex is associated with SpMYH [23], we tested whether hMYH
has any interaction with hHus1, hRad1 and hRad9. The GST-
tagged hHus1, hRad1 and hRad9 proteins were immobilized on
beads and used to pull down partially puriﬁed hMYH. As shown
in Figure 1(A), hMYH bound strongly to GST–hHus1 (lane 2),
bound weakly to GST–hRad1 (lane 3), but not to GST–Rad9
(lane 4). As a negative control, hMYH did not bind to GST
alone (lane 5). Thus hMYH binds to the 9-1-1 complex asym-
metrically. The individual proteins used in Figure 1(A) were
expressed in E. coli; thus hMYH can interact with hHus1 and
hRad1 when they are not in a complex.
The interactions between MYH and the 9-1-1 complex from human
and S. pombe cells are interchangeable
Because we have shown that MYH–PCNA interactions are inter-
changeable between human and S. pombe cells [19], we tested
whether this interchangeable property extends to MYH and the
9-1-1 complex. In binding experiments using GST–hHus1 fusion
Figure 1 Interactions between MYH and the Hus1/Rad1/Rad9 checkpoint
proteins
(A) Pull-down of hMYH by GST–hHus1, GST–Rad1 and GST–Rad9. GST–hHus1 (lane 2),
GST–Rad1 (lane 3), GST–Rad9 (lane 4) and GST alone (lane 5) were immobilized to
glutathione–Sepharose and incubated with partially puriﬁed hMYH, which was tagged with
both GB1 and histidine as described in the Materials and methods section. The pellets were
fractionated by SDS/10% PAGE followed by Western-blot analysis with the hMYH antibody.
Lane 1 contains 10ng (10% of the total input) of partially puriﬁed hMYH. (B) Pull-down of
puriﬁedSpMYHbyGST–hHus1boundtoglutathione–Sepharose.Lane1contains10ng(10%
of the total input) of puriﬁed SpMYH. Lanes 2 and 3 are pull-down pellets from GST–hHus1
and GST alone respectively. The Western blot was detected with the antibody against SpMYH.
(C)InteractionofhMYHwithHA-taggedSpHus1.Cellextracts(0.4 mg)ofS.pombe expressing
HA-taggedSpHus1wereaddedtoGST–hMYHboundtoglutathione–Sepharose.Lane1contains
40µg(10%oftotalinput)ofcellextracts.Lanes2and3arepulleddownpelletsfromGST–hMYH
and GST alone respectively. The Western blot was detected by the antibody against HA.
(D) Interaction of SpMYH with hRad1. Puriﬁed SpMYH can be pull-down by GST–hRad1
bound to glutathione–Sepharose. Lane 1 contains 2.5 ng (2.5% of total input) of puriﬁed
SpMYH. Lanes 2 and 3 are pull-down pellets from GST–hRad1 and GST alone respectively.
The Western blot was detected with the antibody against SpMYH. (E) Interaction of hMYH
with the S. pombe 9-1-1 complex. The partially puriﬁed S. pombe 9-1-1 complex (fraction
FVAd) was added to GST–hMYH bound to glutathione–Sepharose. The SpHus1, SpRad1 and
SpRad9 proteins were tagged with a C-terminal histidine, N-terminal histidine and C-terminal
S-tag respectively. Lane 1 contains 30 ng (10% of total input) of the S. pombe 9-1-1 complex.
Lanes 2 and 3 are pull-down pellets from GST–hMYH and GST alone respectively. TheWestern
blot was detected by a mixture of against S-tag, N-terminal histidine probe and C-terminal
histidine probe.
proteinswithpuriﬁedSpMYH,SpMYHwasdetectedintheGST–
hHus1 pellets (Figure 1B, lane 2), but not in the GST beads
(Figure 1B, lane 3). Conversely, HA-tagged SpHus1 expressed in
yeast cells was detected in the pellets of GST–hMYH (Figure 1C,
lane2),butnotintheGSTbeads(Figure1C,lane3).However,the
interaction between hMYH and SpHus1 is weak. We also tested
whether SpMYH can bind to hRad1. As shown in Figure 1(D),
SpMYH was detected in the GST–hRad1 pellets, but not in the
GST beads. Also, the partially puriﬁed S. pombe 9-1-1 complex
(see Supplementary material) could be pulled-down by GST–
hMYH (Figure 1E, lane 2). Thus the interactions between MYH
and the 9-1-1 complex, from S. pombe and human cells, are par-
tially interchangeable.
Mapping the Hus1 interacting domain within MYH
We have shown that the hPCNA-binding site is located at the
C-terminus of hMYH containing residues 505–527 [20]. To test
whetherhPCNAandhHus1bindtothesameregionofhMYH,we
analysed the hHus1 binding to a truncated hMYH ( C2), which
contains residues 1–504 with the hPCNA-binding motif deleted.
The result (Figure 2A, lane 3) shows that  C2 could associate
with hHus1 in HeLa nuclear extracts. Thus hHus1 and hPCNA
bind to different regions of hMYH.
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Figure 2 Determination of regions within hMYH involved in hHus1 binding
(A)TheGSTpull-downassaywasemployedusingvariousGST–hMYHconstructstodetermine
the binding regions within hMYH for interaction with hHus1 in HeLa nuclear extracts (0.4mg).
Lane1contains15%ofinput(60µg)ofnuclearextracts(NE).Inlanes2–7,GSTfusionproteins,
indicated on top of each lane, were used in the pull-down experiments. INT stands for intact
hMYH. Western-blot analyses of the pellets were performed with the antibody against hHus1. A
control was run concurrently with immobilized GST alone (lanes 8). The results represent four
separateexperimentsinwhich15%oftotalinputisusedasastandardandGSTaloneisusedas
anegativecontrolforeachpull-downanalysis.(B)GraphicdepictionofGST–hMYHconstructs
and the hHus1 binding to the hMYH fusion proteins. The amino acid residues of hMYH in the
GST constructs are indicated. The ‘+’ and ‘–‘ listed on the right of each construct indicate
the presence and absence of hHus1 in the pellets (PPT) of GST beads respectively.
By using constructs containing different portions of hMYH
fusedtoGST,wedeterminedtheregionsofhMYHengagedinthe
physical interaction with the 9-1-1 complex in HeLa nuclear ex-
tracts. These hMYH deletion mutants were constructed based
on the domain structures of prokaryotic MutY [37] and hMYH
molecular model. The results are shown in Figure 2(A) and sum-
marized in Figure 2(B). Constructs  N2 and  C3 retained inter-
action (Figure 2A, lanes 4 and 5); however, construct  C1 ex-
hibited limited interaction (Figure 2A, lane 6) and  N5 had
no binding (Figure 2A, lane 7) with hHus1. Thus the hHus1-
interacting domain is localized to residues 295–350 of hMYH.
Computational analysis of residues 295–350 of hMYH reveals
that several amino acids are conserved among other eukaryotic
MutY family members, including mMYH (mouse MYH) [38],
rMYH (rat MYH) [39] and SpMYH [35] (Figure 3). Based on
known clamp binding signatures [40,41], we expect that the
MYH–Hus1 interaction may involve conserved hydrophobic
residues. The analysis revealed that Val
315 of hMYH and Ile
261 of
SpMYH (marked with a star in Figure 3) are the best candidates
for mediating the binding to Hus1. As shown in Figure 4(A), the
interaction between the V315A mutant of hMYH and Hus1 was
Figure 4 Val315 of hMYH and Ile261 of SpMYH are important for hHus1
binding
The GST pull-down assay was employed similarly to those described in Figure 2.
(A)G S T –  C3hMYH (lanes 2 and 6), GST– C3hMYH(V315A) (lanes 3 and 7) and GST
alone(lanes4and8)wereimmobilizedonbeadsandthenincubatedwithHeLanuclearextracts
(0.4mg) (lanes 2–4) or 100ng of His–hHus1 (lanes 6–8). Lanes 1 and 5 contain 80µg
(20% of total input) of nuclear extracts and 10ng (10% of total input) of puriﬁed His–hHus1
respectively. Western-blot analysis was performed with antibody against hHus1 (lanes 1–4) or
N-terminal histidine probe (lanes 5–8). (B) E. coli extracts containing His–SpHus1 (48µg)
were added to different constructs of GST–hMYH bound to glutathione–Sepharose. Lane 1
contains 10% of input of cell extracts. Lanes 2–6 are pull-down pellets from GST–SpMYH
(wild-type), GST–SpMYH(I261A), GST–SpMYH(245–461), GST–SpMYH(294–461) and GST
alone respectively. Western-blot analysis was performed with antibody against histidine probe.
reduced by approx. 3.5-fold using either HeLa nuclear extracts
(Figure 4A, lanes 2–4) or recombinant hHus1 protein expressed
in E. coli (Figure 4A, lanes 6–8). Previous results indicate that the
C-terminalhalfofSpMYH(residues245–461)containsthemajor
SpHus1-binding site [23]. Consistent with the data of hMYH–
hHus1 binding, SpMYH-(294–461) showed no binding with
SpHus1 (Figure 4B, lane 5). The interaction of SpMYH(I261A)
with SpHus1 (Figure 4B, lane 3) was reduced 5-fold as com-
pared with that of wild-type SpMYH (Figure 4B, lane 2). There-
fore both Val
315 of hMYH and Ile
261 of SpMYH play important
roles in hHus1 binding.
Figure 3 Alignment of the Hus1-binding motifs of MutY homologues
Sequencesare:Homosapiens MYH(hMYH;accessionno.U63329),Musmusculus MYH(mMYH;accessionno.AY007717),Rattusnorvegicus MYH(rMYH;accessionno.NP579850)andSpMYH
(accession no. Z69240). Identical amino acid residues are shaded in black and conserved residues are boxed in grey. Val315 of hMYH and Ile261 of SpMYH are marked by a star.
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Figure 5 The stimulatory activity on SpMYH glycosylase is correlated to the hHus1 and S. pombe 9-1-1 complex peaks during puriﬁcation
(A) SDS/polyacrylamide gel of corresponding hHus1–His fractions from heparin chromatography; 20µl of each fraction was loaded on to each lane and the gel was stained with Coomassie Blue.
(B) SpMYH glycosylase activity is enhanced by hHus1. Lane 11 has DNA substrates containing A/GO. The DNA substrate (0.18nM) was incubated with SpMYH (0.2 nM) (lane 10). Fractions of
hHus1–His protein (1µl of 1:10 dilution) from heparin chromatography were added to the SpMYH glycosylase reactions as in lane 10 (lanes 1–9). Reactions were carried out at 37◦C for 30min
and the products were separated on a 14% DNA sequencing gel. Arrows mark the intact DNA substrate (I) and the nicked product (N). (C) SDS/polyacrylamide gel of corresponding S. pombe 9-1-1
complex fractions from glycerol gradient; 20µl of each fraction was loaded on to each lane and SpRad9, SpRad1 and SpHus1 were analysed by Western blotting with a mixture of antibodies against
S-tag, N-terminal histidine probe and C-terminal histidine probe. (D) SpMYH glycosylase activity is enhanced by the S. pombe 9-1-1 complex. Fractions of S. pombe 9-1-1 complex (1µl) from a
15–35% (v/v) glycerol gradient were added to the SpMYH glycosylase reactions as described in (B). DNA substrate containing A/GO (0.18nM) was incubated with SpMYH (0.2nM) (lane 1).
Human Hus1 and S. pombe 9-1-1 complex can enhance
SpMYH activity
We further tested whether MYH activity can be affected by the
9-1-1 complex. Because it is difﬁcult to express hMYH in E. coli
[4,6] and SpMYH is similar to hMYH in Hus1 binding (Fig-
ures 1B and 1C), we used SpMYH for the activity assays. The
hHus1 protein was puriﬁed to approx. 95% homogeneity (Fig-
ure 5A) and the S. pombe 9-1-1 complex was partially puriﬁed
(seeSupplementaryFigureS1inSupplementarymaterialathttp://
www.BiochemJ.org/bj/400/bj4000053add.htm). The heparin col-
umn fractions of hHus1 were added to the SpMYH glycosylase
reactions with the A/GO-containing DNA substrate. As shown
in Figure 5, the stimulatory activity of the SpMYH glycosylase
(Figure 5B) exactly matches the peak of hHus1 protein as shown
by SDS/PAGE (Figure 5A). The S. pombe 9-1-1 complex was
puriﬁed by a 15–35% glycerol gradient in the ﬁnal step. By com-
parison with the size markers, the S. pombe 9-1-1 complex sedi-
mented at the position indicating a molecular mass of approx.
110 kDa, which is in line with the theoretical value (120 kDa) of
a trimeric complex. By silver staining (Supplementary Figure S1
in Supplementary material) and Coomassie Blue staining (results
not shown), the complex appears to have equal molar amounts
of SpHus1, SpRad1 and SpRad9. The enhancement of SpMYH
glycosylase activity (Figure 5D) is in agreement with the peak
of the S. pombe 9-1-1 complex as detected by Western blotting
(Figure 5C). Therefore hHus1 alone and the S. pombe 9-1-1 com-
plex can stimulate the SpMYH glycosylase activity.
Next, we added increasing amounts of hHus1 and the S. pombe
9-1-1 complex to the SpMYH glycosylase reactions. As shown in
Figure 6(A) (lanes 3–6), the SpMYH glycosylase activity was
enhanced signiﬁcantly by hHus1–His protein. The difference
between SpMYH (0.2 nM) alone and SpMYH with 15 nM of
hHus1was5-fold(Figure6C,opencircles).Similarstimulationof
the SpMYH glycosylase activity was observed with the partially
puriﬁed S. pombe 9-1-1 complex (Figure 6A, lanes 9–12). The
difference between SpMYH (0.2 nM) alone and SpMYH with
5n Mo fS. pombe 9-1-1 complex was 5.5-fold (Figure 6D, open
squares). Interestingly, the concentrations of human hHus1 and
the S. pombe 9-1-1 complex required to produce a given stimul-
atory effect on SpMYH glycosylase are similar to one another
(e.g. 15 nM Hus1 is equivalent to 5 nM of the 9-1-1 complex).
hHus1 and the S. pombe 9-1-1 complex did not have any adenine
glycosylase activity at the highest tested concentrations (results
not shown). In addition, E. coli histidine-tagged β-clamp and
hPCNA could not stimulate the SpMYH glycosylase activity
(results not shown). The SpMYH binding to A/GO mismatch
was only slightly enhanced by hHus1 protein and the S. pombe
9-1-1 complex (Figure 6B).
The puriﬁed SpMYH(I261A) mutant protein was shown to ex-
hibit similar glycosylase activity as the wild-type enzyme (results
not shown). Consistent with its reduced physical interaction
with SpHus1, SpMYH(I261A) required greater amounts of
hHus1(Figure6C,closedcircles)andtheS.pombe9-1-1complex
(Figure6D,closedsquares)forstimulation.HumanHus1(15 nM)
andtheS.pombe9-1-1complex(5 nM)stimulatedtheglycosylase
activity of SpMYH(I261A) by approx. 3-fold.
Like many DNA glycosylases, MYH exhibits slow enzymatic
turnover due to strong binding to its AP (apurinic/apyrimidinic)/
GO product [38]. The glycosylase assays carried out in Fig-
ure 6 measured the steady-state kinetics and could not determine
which step of the DNA glycosylase reaction is affected by
Hus1 and the 9-1-1 complex. Using single turnover kinetics and
saturating enzyme conditions (Figure 7), SpMYH removed A
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Figure 6 hHus1 and the S. pombe 9-1-1 complex stimulate SpMYH activity
(A) SpMYH glycosylase activity with A/GO-containing DNA was stimulated by hHus1 and S. pombe 9-1-1 complex. Lanes 1 and 7 include DNA substrates containing A/GO. In lanes 2 and 8, the
DNA substrates (0.18nM) were incubated with SpMYH (0.2nM). In lanes 3–6, the DNA substrates (0.18nM) were incubated with 0.2 nM SpMYH and 3.13, 6.25, 12.5 and 25nM of His-hHus1
(fraction 61 of heparin chromatography). In lanes 9–12, the DNA substrates (0.18nM) were incubated with 0.2 nM SpMYH and 0.63, 1.25, 2.5 and 5 nM of S. pombe 9-1-1 complex. The reactions
were carried out at 37◦C for 30min. The products were separated on a 14% DNA sequencing gel. Arrows mark the intact DNA substrate (I) and the nicked product (N). (B) SpMYH binding
to A/GO-containing DNA was slightly stimulated by hHus1 and S. pombe 9-1-1 complex. Lane 1 has DNA substrates containing A/GO. In lanes 2 and 6, the DNA substrates (0.18nM) were
incubated with 0.2 nM SpMYH. In lanes 3–5, the DNA substrates (0.18nM) were incubated with 0.2nM SpMYH and 6.25, 12.5 and 25nM of His–hHus1 (fraction 61 of heparin chromatography).In
lanes 7–9, the DNA substrates (0.18nM) were incubated with 0.2 nM SpMYH and 1.25, 2.5 and 5 nM of S. pombe 9-1-1 complex (the pooled fraction from phosphocellulose chromatography,
FVAd). The products were fractionated on a 6% non-denaturing gel. Arrows indicate the positions of the SpMYH–DNA complex (Bound) and free DNA substrate (Free). (C, D) Quantitative analyses
of fold stimulation of hHus1 and S. pombe 9-1-1 complex respectively, on wild-type (open circles and open squares) and I261A mutant (closed circles and closed squares) SpMYH glycosylase
activities from three experiments. The error bars reported are the standard deviations of the averages.
Figure7 TimecoursestudiesofSpMYHglycosylaseactivityinthepresence
of hHus1
The DNA substrates containing A/GO (0.18nM) were incubated with 1.8nM SpMYH in the
absence(opencircles)orpresence(closedcircles)of18nMHis–hHus1(fraction61ofheparin
chromatography).Reactionswerecarriedoutat23◦Cforvarioustimeintervals.Thepercentages
of DNA cleaved were plotted as a function of time. Data were obtained from phosphoimager
quantitative analyses of gel images over three experiments. The error bars reported are the
standard deviations of the averages. The rate constants were determined by ﬁtting of the data to
a single exponential equation: P =Pf(1–e−kt) where P is the percentage of cleavage, Pf is the
ﬁnal value P, t is the time and k is the rate constant.
from A/GO mispairs with a rate of kobs =0.80+ −0.17 min
−1 at
room temperature. In the presence of 10-fold excess of hHus1,
the rate of kobs was increased to 1.98+ −0.34 min
−1. Thus the
rate of the MYH glycosylase activity is increased by 2.5-fold by
Hus1.
DNA damage stimulates hMYH–hHus1 interaction
To investigate any alterations of hMYH–hHus1 interaction fol-
lowing DNA damage, we performed co-immunoprecipitation ex-
periments with extracts from ionizing-radiation-treated HeLa
cells. In these experiments, hHus1 could be immunoprecipitated
by hMYH antibodies from HeLa cell extracts (Figure 8A, lanes 2,
4, 6 and 8), further conﬁrming the physical interaction of hHus1
and hMYH. Interestingly, the interaction between hMYH and
hHus1 was enhanced after ionizing radiation treatment. In un-
treatedcells,thehMYH–hHus1interactionwasweak(Figure8A,
lane 2). Exposure to 10 Gy ionizing radiation resulted in an
increased hMYH–hHus1 interaction, which reached a peak at
6 h after ionizing radiation treatment (Figure 8A, lane 6). At 24 h
after ionizing radiation treatment, the hMYH–hHus1 interaction
was then reduced to a level similar to that found in the untreated
extracts (Figure 8A, lanes 2 and 8). In contrast, the hMYH–
hPCNA interaction had minimal changes after ionizing radiation
treatment(Figure8B).ThehMYH–hPCNAinteractionwasstrong
in untreated cells (Figure 8B, lane 2) and was slightly weaker at
24 h after ionizing radiation treatment (Figure 8B, lane 8). We
also determined the total protein levels in cell extracts by direct
Westernblotting.TheproteinlevelofhHus1wasincreased,while
hPCNA and hMYH levels remained almost the same after ioniz-
ing radiation treatment (Figures 8C–8F). At 24 h after ionizing
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Figure 8 The interaction of hHus1 and hMYH is enhanced upon ionizing
radiation
HeLa cells were exposed to 10 Gy X-rays or left unirradiated (UN) and recovered for various
times as indicated. Total cell extracts were prepared and analysed by immunoprecipitation with
antibody against hMYH. S represents the supernatant and P represents the pellet. Western
blotting was performed to detect hHus1 (A) and hPCNA (B). (C–F) Protein expression in
irradiated HeLa cells. Extracts were subjected to direct Western blotting to detect hHus1 (C),
hPCNA (D), hMYH (E)a n dβ-actin (F).
radiation treatment, while the hHus1 protein level was still elev-
ated (Figure 8C, lane 4), the hHus1–hMYH interaction was de-
creased (Figure 8A, lane 8). The results of Figure 8 indicate
that hMYH–hHus1 interaction is enhanced following ionizing
radiation treatment, which probably induces oxidative DNA
damage.
Co-localization of hMYH with hRad9 in nuclear foci after
oxidative stress
Based on the above results, we determined whether hMYH and
hRad9 move to the same nuclear foci following H2O2 treatment.
By immunoﬂuorescent staining analyses, both hMYH and hRad9
appeared granulated in faint spots throughout the nucleus of
untreated HeLa cells (Figures 9B and 9C). Some hMYH protein
molecules were localized to cytoplasm (Figure 9B). In H2O2-
treated cells, hMYH and hRad9 form discrete nuclear foci (Fig-
ures 9F and 9G). A signiﬁcant fraction of the hMYH nuclear foci
were found to co-localize with hRad9 foci in H2O2-treated cells
(Figure 9H). Because oxidative stress generates many types of
oxidized DNA base lesions, hRad9 may form foci with other pro-
tein partners. Together with the co-immunoprecipitation results,
our results indicate that hMYH and the 9-1-1 complex translocate
to some lesion sites following DNA damage.
DISCUSSION
DNA damage checkpoints are surveillance mechanisms that
ensure a proper cellular response to stress and maintain genome
stability (reviewed in [9]). The checkpoint proteins Rad9, Rad1
and Hus1 are proposed to function as damage sensor proteins.
However, the mechanisms involved in the sensing step of these
proteins are still poorly understood. In the present study, we show
that Hus1 and the 9-1-1 complex interact with and stimulate
MYH DNA glycosylase. Human MYH physically interacts with
Hus1 and Rad1, but not with Rad9. hMYH can interact with
hHus1 even in the absence of hRad1 and hRad9. Also, we have
observed similar asymmetrical interactions between the S. pombe
9-1-1 complex and SpMYH [23]. Because E. coli β-clamp and
hPCNA cannot stimulate the SpMYH glycosylase activity, the
9-1-1 complex exhibits a damage-speciﬁc enhancement on MYH
baseexcisionrepair.The9-1-1complexmayreplacePCNAwhen
the active PCNA concentration is low, such as when PCNA is
inactivated by p21 during cell-cycle arrest in response to DNA
damage [42].
The major Hus1-interacting region is localized to residues
295–350 of hMYH and residues 245–293 of SpMYH (Figure 3),
which are different from their PCNA-binding sites [19,20]. A
consensus PCNA-binding motif [QXX(L/V)XXF(F/Y)] is found
Figure 9 Co-localization of hMYH with hRad9 following oxidative stress
HeLa cells were not treated with H2O2,a si n( A–D), or treated with 5mM H2O2 for 40min and then recovered for 6 h as in (E–H). The cells were stained with antibody against hMYH (green, B, F)
and anti-hRad9 antibody (red, C, G). (A, E) DAPI-stained nuclei. (D) is the merged images of (B)a n d( C). (H) is the merged images of (F)a n d( G). Co-localization of hMYH (green) and hRad9 (red)
is visualized as yellow.
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in many proteins involved in DNA replication, DNA repair, DNA
methylation and chromatin assembly [43,44]. Recently, the list
of proteins that interact with 9-1-1 has been expanding, yet the
interacting regions within these proteins have not been mapped
to speciﬁc motifs. Thus the consensus Hus1-, Rad1- and Rad9-
binding motifs and how they differ from the PCNA-binding
signature are still to be determined. Here, we show that Val
315
of hMYH and Ile
261 of SpMYH play important roles for their
interactions with Hus1. Although PCNA and the 9-1-1 complex
interact at different regions of MYH, their points of contact with
MYH appear to involve hydrophobic interactions. The region
containing residues 295–350 of hMYH is conserved among
eukaryotic MutY family members (Figure 3). The molecular
model of hMYH, based on the prokaryotic MutY structure [37],
indicates that this region is part of the N-terminal domain and is
close to the junction with the C-terminal domain (Supplementary
Figure S2 in Supplementary material at http://www.BiochemJ.
org/bj/400/bj4000053add.htm). The region represents a long in-
sertion compared with prokaryotic MutY proteins. The results
from both secondary structure [45] and disorder [46] prediction
suggest that this insertion is likely unstructured in solution when
hMYH is in unbound form. Our model suggests that the 9-1-1
complex may interact with MYH and then promote the catalytic
activity of MYH. Wang et al. [28] have suggested that the stimul-
ation mechanism of human DNA ligase 1 by the 9-1-1 complex
does not involve a structural change in the DNA ligase nor
requires encirclement of the DNA. Thus a direct protein–protein
interaction may mediate the role of the 9-1-1 complex in base
excisionrepair. Itisinteresting tonotethat thehHus1-bindingdo-
main of hMYH (residues 295–350) overlaps with the binding
domain of APE1 (AP endonuclease 1) on hMYH (residues
295–318) [20]. Yang et al. [38] have reported that APE1 can sti-
mulate MYH glycosylase activity and turnover from its AP/G
(AP/guanine) products. We did not observe signiﬁcant enhance-
ment of SpMYH binding to A/GO mismatches by Hus1 protein
(Figure 6B), nor the ternary complex of DNA–MYH–Hus1. It
remains to be tested whether hHus1 enhances MYH release from
AP/GO-DNA products.
Stimulation of MYH glycosylase activity requires substantial
molar excess of Hus1 and the 9-1-1 complex over MYH protein.
With 75-fold and 25-fold molar excess of hHus1 and S. pombe
9-1-1 complex respectively, SpMYH glycosylase activity was
stimulated approx. 5-fold (Figures 6C and 6D). The results
suggestthatthe9-1-1complexmayfunctionmoreefﬁcientlythan
the Hus1 alone or that hHus1 may not fully substitute SpHus1
to stimulate SpMYH activity. Alternatively, Hus1 may form a
homotrimer since Hus1 can interact with itself [47,48]. Because
Hus1 by itself can stimulate MYH activity, it remains to be deter-
mined whether 9-1-1 clamp formation or clamp loading to DNA
is necessary for the stimulation. The required molar excess is
also observed in the stimulation by the 9-1-1 complex of FEN1
[25,26], polymerase β [24] and DNA ligase 1 [27,28].
The association of MYH with the 9-1-1 complex is similar
in both human and S. pombe cells [23]. First, MYH physically
interacts with the Rad9–Rad1–Hus1 complex mainly via the
Hus1 subunit. Secondly, the physical and functional interactions
of MYH–Hus1 and MYH–Rad1 from S. pombe and human
cells are interchangeable. It is interesting to note that MYH–Hus1
interactions, just like MYH–PCNA interactions, are interchange-
able despite the fact that human and S. pombe Hus1 proteins
share only 28% identical residues compared with 50% identity
between corresponding PCNA proteins. Thirdly, interactions be-
tween MYH and Hus1 proteins are stress-inducible. hMYH–
hHus1 interaction reached a peakat 6 h andreduced to a low level
at 24 h following ionizing radiation treatment. The interaction
between SpHus1 and SpMYH reached a peak at 3 h and then
decreased after 6 h following H2O2 treatment [23]. In contrast,
the MYH–PCNA interaction had minimal changes after stress in
both organisms. In addition, a signiﬁcant fraction of the hMYH
nuclear foci was found to co-localize with hRad9 foci in H2O2-
treated human cells. Along with the similarities, we also observed
twodifferencesintheassociationofMYHwiththe9-1-1complex
betweenhumanandS.pombecells.First,wehavereportedthatthe
increase in the SpHus1–SpMYH interaction correlates with
the presence of SpHus1 phosphorylation following H2O2 treat-
ment. However, we did not observe mobility change of hHus1
after ionizing radiation treatment. Thus the state of hHus1 phos-
phorylation is unclear. Secondly, the protein level of hHus1 in-
creases up to 24 h following ionizing radiation treatment, while
SpHus1 protein level remains unchanged after H2O2 treatment
[23].
How the sensor checkpoint proteins detect different types of
DNA lesions remains elusive. Zou and Elledge [14] have shown
that RPA-coated single-stranded DNA may be the common inter-
mediate of many DNA repair pathways to recruit ATR/ATRIP
(ATR-interacting protein). Several reports suggest that the sensor
proteinsmayneedaseriesofadaptorproteinsfortheirrecruitment
to the lesion sites. The nucleotide excision repair proteins Rad14
[hXPA (human xeroderma pigmentosum group A) homologue]
and Rad1 [hXPF (human xeroderma pigmentosum group F)
homologue] of S. cerevisiae, as well as hXPA, are required for the
damage response [49,50]. Direct interactions between ScRad14
(hXPA homologue) and the checkpoint proteins ScDdc1 (hRad9
homologue) and ScMec3 (hHus1 homologue) have been demon-
strated [16]. In addition, human mismatch repair enzyme MSH2
(MutS homologue 2) interacts with the ATR in response to alkyl-
ating agents [18]. Brown et al. [51] have shown that MSH2 inter-
acts with CHK2 and that MLH1 (MutL homologue 1) associates
with ATM. Recently, Pandita et al. have shown that hRad9 inter-
acts with recombination protein Rad51 and telomeric protein
TRF2 [52]. The Mre11–Rad50–Nbs1 complex has been shown
to sense double-strand breaks in DNA and to activate cell-cycle
checkpoint pathways after exposure to radiation (reviewed in
[17]).
Our results from current and previous studies [23] with human
and S. pombe cells support the model that MYH may be one of
the adaptors for sensor checkpoint proteins following oxidative
DNA damage. Particularly, DNA-damage-induced SpHus1 phos-
phorylation is dependent on SpMYH expression [23]. In this
model, MYH ﬁrst recognizes the lesions and then recruits Rad9–
Rad1–Hus1. Alternatively, the 9-1-1 complex may be loaded to
DNA by Rad17–RFC and then it interacts and stimulates MYH.
The 9-1-1 complex at the lesion sites serves both as a damage
sensor to activate checkpoint control and as a component of base
excision repair to enhance MYH glycosylase (Figures 7 and 8)
anddownstreampolymeraseβ,FEN1andDNAligase1activities
[24–28,53]. Our ﬁndings provide new insight on the initiation
of signal transduction mechanism following DNA damage. In
addition, other DNA damage recognition proteins may serve to
recruit checkpoint proteins to different lesion sites. It is also
possible that the damage-recognition involves a large complex
such as BASC [BRCA1 (breast-cancer susceptibility gene 1)-
associated genome surveillance complex], which contains DNA
repairandreplicationproteins,includingBRCA1,MSH2,MSH6,
MLH1,ATM,RAD50andRFC[54].DNAdamageresponsemay
be co-ordinated with ongoing DNA repair.
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